Avadel Pharmaceuticals
AVDL
#4772
Rank
$2.12 B
Marketcap
$21.64
Share price
0.00%
Change (1 day)
174.97%
Change (1 year)

Operating Margin for Avadel Pharmaceuticals (AVDL)

Operating Margin as of November 2026 (TTM): -1.31%

According to Avadel Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -1.31%. At the end of 2020 the company had an Operating Margin of -22.75%.

Operating Margin history for Avadel Pharmaceuticals from 2001 to 2020

Operating Margin at the end of each year

Year Operating Margin Change
2020-22.75%-65.08%
2019-65.16%-40.56%
2018-109.61%-304.94%
201753.48%-926.91%
2016-6.47%-114.29%
201545.26%-107.4%
2014-611.38%153.65%
2013-241.03%693.34%
2012-30.38%15.41%
2011-26.33%11.4%
2010-23.63%-12.99%
2009-27.16%-43.49%
2008-48.06%-55.32%
2007-107.58%-33.64%
2006-162.12%20.82%
2005-134.18%-899.6%
200416.78%-205.66%
2003-15.88%-219.22%
200213.32%-160.96%
2001-21.85%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
OPKO Health
OPK
-31.72% 2,321.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-8,391.15% 640,445.80%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.